As digital technologies increase the occurrence of big bang disruptions across industries, companies old and new find they have less time both to profit from their own disruptor and to unleash the next one. This article describes the drivers of this phenomenon, and offers strategic responses...

The nature of disruptive innovation, first studied by Joseph Schumpeter, has changed dramatically in the wake of rapidly and predictably deflating costs for embedded digital technology. New disruptors now enter the marker both better and cheaper than existing products. The result is devastating...

This paper studies how competition impacts innovative firms’ voluntary disclosure of product quality information. Our empirical context is the pharmaceutical industry, where firms must decide whether to disclose drug quality information acquired in clinical trials. Leveraging variation in...

The regulation on prescribing and dispensing of antibiotics has a double purpose: to enhance access to antibiotic treatment and to reduce the inappropriate use of drugs. Nevertheless, incentives to dispensing physicians may lead to inefficiencies. We sketch a theoretical model of the market for...

The benefits of separating drug prescribing and dispensing are still unclear, in particular when drug consumption is characterized by important spillovers. We investigate the role of dispensing physicians in the consumption of antibiotics characterized by two opposite external effects: infection...

Regulation of prescription and dispensing of antibiotics has a twin purpose: to enhance access to antibiotic treatment and to reduce inappropriate use of drugs. Nevertheless, incentives on antibiotics to dispensing physicians may lead to inefficiencies. We model the interaction between competing...

The regulation on prescribing and dispensing of antibiotics has a double purpose: to enhance access to antibiotic treatment and to reduce the inappropriate use of drugs. Nevertheless, incentives to dispensing physicians may lead to inefficiencies. We sketch a theoretical model of the market for...

The exchange of information among competitors has been debated ever since the beginnings of Antitrust Law, but manages to stay a 'hot topic' - from Eddy's 'New Competition' in 1912 to the B2B platform discussions in the early 2000s and the recent guidance on information exchange in the European...

Policymakers and market intermediaries often use quality scores to alleviate asymmetric information about product quality. Scores affect the demand for quality and, in equilibrium, its supply. Equilibrium effects break the rule whereby more information is always better, and the optimal design of...

Medical and nursing care have been separated from social care by deliberate design since the creation of the NHS. This divide is now entirely artificial. People spend less time in hospital than used to be the case and 4 million people over the age of 65 have a life-limiting illness. In such...